Published in Lancet Infect Dis on February 27, 2012
Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet (2014) 4.25
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. Eur Respir J (2014) 2.28
Epidemiology of drug-resistant tuberculosis among children and adolescents in South Africa, 2005-2010. Int J Tuberc Lung Dis (2015) 1.43
Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence. Clin Infect Dis (2012) 1.28
Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India. PLoS One (2013) 1.25
Multidrug-resistant tuberculosis in children: evidence from global surveillance. Eur Respir J (2012) 1.03
Outcomes of comprehensive care for children empirically treated for multidrug-resistant tuberculosis in a setting of high HIV prevalence. PLoS One (2012) 1.00
Outcomes of children treated for tuberculosis with second-line medications in Georgia, 2009-2011. Int J Tuberc Lung Dis (2013) 0.94
The effect of early versus late treatment initiation after diagnosis on the outcomes of patients treated for multidrug-resistant tuberculosis: a systematic review. BMC Infect Dis (2016) 0.88
Poor treatment outcomes among multidrug-resistant tuberculosis patients in Gomel Region, Republic of Belarus. Public Health Action (2014) 0.88
Global Burden of Childhood Tuberculosis. Pneumonia (Nathan) (2016) 0.85
Tuberculosis in children. Mediterr J Hematol Infect Dis (2013) 0.85
Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in Children. J Pediatric Infect Dis Soc (2013) 0.82
A systematic follow-up of Mycobacterium tuberculosis drug-resistance and associated genotypic lineages in the French Departments of the Americas over a seventeen-year period. Biomed Res Int (2014) 0.82
Advances in Drug Discovery and Development for Pediatric Tuberculosis. Mini Rev Med Chem (2016) 0.82
Paediatric Multidrug-Resistant Tuberculosis with HIV Coinfection: A Case Report. Case Rep Med (2013) 0.80
Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis (2016) 0.79
Drug-resistant tuberculosis in two children in Greece: report of the first extensively drug-resistant case. Eur J Pediatr (2012) 0.77
Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis. Pneumonia (Nathan) (2016) 0.77
Tuberculosis in children. Cold Spring Harb Perspect Med (2014) 0.76
Multidrug-resistant tuberculosis in children can be treated. Lancet Infect Dis (2012) 0.75
Treating drug-resistant tuberculosis in a low-intensity chronic conflict setting in India. Confl Health (2014) 0.75
Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen. Emerg Infect Dis (2015) 0.75
Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis. Syst Rev (2017) 0.75
Map the gap: missing children with drug-resistant tuberculosis. Public Health Action (2015) 0.75
[Multidrug-resistant tuberculosis in children: about two cases]. Pan Afr Med J (2016) 0.75
Setting priorities for a research agenda to combat drug-resistant tuberculosis in children. Public Health Action (2015) 0.75
Intensified specimen collection to improve tuberculosis diagnosis in children from Rural South Africa, an observational study. BMC Infect Dis (2014) 0.75
Pediatric Multidrug Resistant Tuberculosis Clinical Trials: Challenges and Opportunities. Int J Infect Dis (2016) 0.75
Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet (2002) 11.72
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet (2006) 10.91
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet (2010) 10.21
HIV status in discordant couples in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis (2010) 6.95
A systematic review of task- shifting for HIV treatment and care in Africa. Hum Resour Health (2010) 6.48
Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS (2010) 5.46
Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis (2007) 5.27
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS (2006) 5.13
Technologies for global health. Lancet (2012) 5.05
25 years of the WHO essential medicines lists: progress and challenges. Lancet (2003) 4.95
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med (2012) 4.69
Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med (2011) 4.68
HIV viral load monitoring in resource-limited regions: optional or necessary? Clin Infect Dis (2006) 4.56
The financial cost of doctors emigrating from sub-Saharan Africa: human capital analysis. BMJ (2011) 4.54
Global distribution and prevalence of hepatitis C virus genotypes. Hepatology (2014) 3.95
Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull World Health Organ (2009) 3.77
Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS (2012) 3.50
Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis (2002) 3.46
Localized spatial clustering of HIV infections in a widely disseminated rural South African epidemic. Int J Epidemiol (2009) 3.42
Male sex and the risk of mortality among individuals enrolled in antiretroviral therapy programs in Africa: a systematic review and meta-analysis. AIDS (2013) 3.17
The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine (2006) 3.16
Towards universal voluntary HIV testing and counselling: a systematic review and meta-analysis of community-based approaches. PLoS Med (2013) 3.15
Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc (2012) 3.00
Distribution of antiretroviral treatment through self-forming groups of patients in Tete Province, Mozambique. J Acquir Immune Defic Syndr (2011) 2.97
Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr (2011) 2.96
Does ratification of human-rights treaties have effects on population health? Lancet (2009) 2.93
Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care. Trop Med Int Health (2010) 2.92
Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries. Clin Infect Dis (2014) 2.80
Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes? Bull World Health Organ (2010) 2.72
Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Lancet Infect Dis (2013) 2.71
Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med (2006) 2.68
Is operational research delivering the goods? The journey to success in low-income countries. Lancet Infect Dis (2012) 2.62
Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med (2012) 2.60
Expanding HIV care in Africa: making men matter. Lancet (2009) 2.54
Should active recruitment of health workers from sub-Saharan Africa be viewed as a crime? Lancet (2008) 2.31
Antiretroviral treatment outcomes from a nurse-driven, community-supported HIV/AIDS treatment programme in rural Lesotho: observational cohort assessment at two years. J Int AIDS Soc (2009) 2.31
Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. Pediatrics (2007) 2.24
A comparison between two strategies for monitoring hepatic function during antituberculous therapy. Am J Respir Crit Care Med (2011) 2.22
Rational use of moxifloxacin for tuberculosis treatment. Lancet Infect Dis (2011) 2.21
A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics (2006) 2.21
Decentralising HIV treatment in lower- and middle-income countries. Cochrane Database Syst Rev (2013) 2.17
Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis (2013) 2.16
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ (2006) 2.13
Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: a cohort analysis. PLoS One (2011) 2.11
Moxifloxacin for Buruli ulcer/HIV coinfected patients: kill two birds with one stone? AIDS (2013) 2.05
Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors. J Acquir Immune Defic Syndr (2010) 2.05
Mortality, violence and lack of access to healthcare in the Democratic Republic of Congo. Disasters (2003) 2.04
Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. AIDS (2012) 2.03
Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS One (2013) 2.03
Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review. Trop Med Int Health (2011) 2.02
Acquired drug resistance during inadequate therapy in a young child with tuberculosis. Pediatr Infect Dis J (2014) 2.02
HIV treatment in a conflict setting: outcomes and experiences from Bukavu, Democratic Republic of the Congo. PLoS Med (2007) 1.94
Operative mortality in resource-limited settings: the experience of Medecins Sans Frontieres in 13 countries. Arch Surg (2010) 1.89
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis (2012) 1.89
Role and outcomes of community health workers in HIV care in sub-Saharan Africa: a systematic review. J Int AIDS Soc (2013) 1.82
Childhood tuberculosis: an emerging and previously neglected problem. Infect Dis Clin North Am (2010) 1.78
Implementing a tenofovir-based first-line regimen in rural Lesotho: clinical outcomes and toxicities after two years. J Acquir Immune Defic Syndr (2011) 1.74
Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis (2012) 1.72
Challenges and opportunities for the implementation of virological testing in resource-limited settings. J Int AIDS Soc (2012) 1.66
Community-supported models of care for people on HIV treatment in sub-Saharan Africa. Trop Med Int Health (2014) 1.58
Similar mortality and reduced loss to follow-up in integrated compared with vertical programs providing antiretroviral treatment in sub-saharan Africa. J Acquir Immune Defic Syndr (2012) 1.58
Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda. PLoS One (2011) 1.56
Surgical task shifting in Sub-Saharan Africa. PLoS Med (2009) 1.56
Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda. AIDS (2011) 1.55
Feasibility of HIV point-of-care tests for resource-limited settings: challenges and solutions. BMC Med (2014) 1.51
Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet (2003) 1.51
A proposed radiological classification of childhood intra-thoracic tuberculosis. Pediatr Radiol (2004) 1.50
Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis. AIDS (2013) 1.49
Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy. BMC Pediatr (2008) 1.49
HIV-1 viral load monitoring: an opportunity to reinforce treatment adherence in a resource-limited setting in Thailand. Trans R Soc Trop Med Hyg (2008) 1.48
Viral load monitoring as a tool to reinforce adherence: a systematic review. J Acquir Immune Defic Syndr (2013) 1.46
Male gender predicts mortality in a large cohort of patients receiving antiretroviral therapy in Uganda. J Int AIDS Soc (2011) 1.46
Lessons learned during down referral of antiretroviral treatment in Tete, Mozambique. J Int AIDS Soc (2009) 1.46
The tuberculosis challenge in a rural South African HIV programme. BMC Infect Dis (2010) 1.46
When best practice is bad medicine: a new approach to rationing tertiary health services in South Africa. S Afr Med J (2008) 1.45
Community-based antiretroviral therapy programs can overcome barriers to retention of patients and decongest health services in sub-Saharan Africa: a systematic review. Int Health (2013) 1.42
Expert reviews: who are they for? Expert Opin Pharmacother (2012) 1.39
Short intensified treatment in children with drug-susceptible tuberculous meningitis. Pediatr Infect Dis J (2014) 1.35
Culture-confirmed multidrug-resistant tuberculosis in children: clinical features, treatment, and outcome. Clin Infect Dis (2011) 1.33
Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med (2007) 1.33
Outcome of HIV infected children with culture confirmed tuberculosis. Arch Dis Child (2005) 1.30
Expanding access to treatment for hepatitis C in resource-limited settings: lessons from HIV/AIDS. Clin Infect Dis (2012) 1.30
Beijing and Haarlem genotypes are overrepresented among children with drug-resistant tuberculosis in the Western Cape Province of South Africa. J Clin Microbiol (2006) 1.28
Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines. Clin Infect Dis (2009) 1.28
B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection. Nat Commun (2010) 1.26
Antiretroviral therapy outcomes among adolescents and youth in rural Zimbabwe. PLoS One (2012) 1.26
Cesarean section rates and indications in sub-Saharan Africa: a multi-country study from Medecins sans Frontieres. PLoS One (2012) 1.25
Scaling up antiretroviral therapy in resource-limited settings: adapting guidance to meet the challenges. Curr Opin HIV AIDS (2013) 1.23
Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations. Trans R Soc Trop Med Hyg (2005) 1.22
An integrated approach of community health worker support for HIV/AIDS and TB care in Angónia district, Mozambique. BMC Int Health Hum Rights (2009) 1.21
Universal access: the benefits and challenges in bringing integrated HIV care to isolated and conflict affected populations in the Republic of Congo. Confl Health (2009) 1.21
Renal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural Lesotho. PLoS One (2011) 1.21
Paediatric use of second-line anti-tuberculosis agents: a review. Tuberculosis (Edinb) (2011) 1.19
Paediatric radiology seen from Africa. Part I: providing diagnostic imaging to a young population. Pediatr Radiol (2011) 1.19
Public health. Getting HIV treatment to the most people. Science (2012) 1.19
T-cell immunophenotyping distinguishes active from latent tuberculosis. J Infect Dis (2013) 1.18
Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother (2012) 1.17
Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice. J Antimicrob Chemother (2011) 1.16